Acupuncture for Chronic Pelvic Pain
Unknown statusNot applicableNCT05223517
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of the study is to assess the effects and safety of acupuncture for moderate to severe chronic pelvic pain in women.
Study details
- Official title
- Effect of Acupuncture for Chronic Pelvic Pain in Women: a Randomized Clinical Trial
- Conditions
- Acupuncture, Chronic Pelvic Pain, Woman
- Interventions
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Start date
- 2022-03-06
- Primary completion
- 2024-09
- Sex
- Female
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patients aged between 18 and 50. * Chronic pelvic pain (with or without dysmenorrhoea or dyspareunia) of at least 6 months duration. * Having not used medications, other than rescue medicine, or therapies for chronic pelvic pain for at least 4 weeks before randomization, and consenting not to use throughout the process of the research. * Completing Weekly Pain Diary for at least three week during the four-week run-in period, and at least two of the worst pain scoring ≥4 on the Numeric Rating Scale. * Volunteering to participate the trial and signing written informed consent. Exclusion Criteria: * Cyclical chronic pelvic pain, such as only with dysmenorrhea. * Endometriosis. * Adenomyosis. * Complex ovarian cyst. * Accessory cyst \>5cm. * Uterine fibroids \>5cm. * Malignant disease. * Anterior sacral neurectomy or uterine sacral nerve ablation before or scheduled in the next 6 month. * Irritable bowel syndrome. * Symptomatic urinary tract infection. * Acute pelvic inflammation. * Uncontrolled vaginitis. * Lactation period, pregnancy, or fetation planned in the next 6 months. * Sever disorders in heart, lung, brain, liver, kidney and hematopoietic system, or obvious psychiatric or cognitive dysfunction. * Poor adherence.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05223517